Status:
RECRUITING
Efficacy of the NXSignal Device for the Treatment of Anterior Cruciate Ligament Injuries
Lead Sponsor:
University of Las Palmas de Gran Canaria
Conditions:
Anterior Cruciate Ligament Injuries
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
Injury to the anterior cruciate ligament (ACL) is very common among sports professionals and the general population \[. Unlike other joint injuries, it is reversible, but it can damage adjacent tissue...
Detailed Description
The design of this study is a randomised, triple blind clinical trial with placebo control. The general configuration of the study consists of capturing a group of patients treated with the same ACL ...
Eligibility Criteria
Inclusion
- Over 16 years old
- In normal conditions and mentally competent to participate in the study.
- Not having previous knee surgeries.
- In condition to complete the study questionnaires.
Exclusion
- Present some of the contraindications for a treatment with NESA XSIGNAL®: pacemakers, internal bleeding, do not apply electrodes on skin in poor condition, with ulcerations or wounds, acute febrile processes, acute thrombophlebitis and / or electricity phobia.
- Not having signed the informed consent.
- Urgent surgical interventions.
Key Trial Info
Start Date :
May 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 25 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05207943
Start Date
May 25 2021
End Date
December 25 2025
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Las Palmas de Gran Canaria
Las Palmas de Gran Canaria, Las Palmas, Spain, 35016